NTx Expands Scientific Advisory Board with Appointment of RNA Biology Pioneer Dr. Jeff Coller

NTx, a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the appointment of Dr. Jeff Coller, Bloomberg Distinguished Professor of RNA Biology and Therapeutics at Johns Hopkins University, to its Scientific Advisory Board (SAB).